Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19
- 1 January 2021
- Vol. 113 (1) , 1129-1140
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research
- Department of Science and Technology
This publication has 112 references indexed in Scilit:
- Emerging Theme: Cellular PDZ Proteins as Common Targets of Pathogenic VirusesJournal of Virology, 2011
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Receptors for acylethanolamides—GPR55 and GPR119Prostaglandins & Other Lipid Mediators, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Assessment of programs for ligand binding affinity predictionJournal of Computational Chemistry, 2008
- Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging InfectionClinical Microbiology Reviews, 2007
- Conductance and amantadine binding of a pore formed by a lysine‐flanked transmembrane domain of SARS coronavirus envelope proteinProtein Science, 2007
- Exceptional Flexibility in the Sequence Requirements for Coronavirus Small Envelope Protein FunctionJournal of Virology, 2007
- SWISS-MODEL: an automated protein homology-modeling serverNucleic Acids Research, 2003